CDT CDT Equity Inc.
USHealthcareAs of 2026-07-10 16:00
Why CDT matters now
CDT Equity Inc. (CDT) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.38 with -7.02% on the session and $1.9M in market capitalization; recent performance reads 1-month -15.00% and YTD -96.81%.
The latest financial table shown here is Q1 2026, with revenue of $696.4M, net income of $51.0M, and EPS of $1,300.00. Investors can compare that operating picture with valuation signals such as P/E 0.00 and FCF yield -120.2%.
The latest indexable market news headline is "CDT Environmental Technology Investment Holdings Regains Compliance with Nasdaq Minimum Bid Price Requirement" from GlobeNewsWire.
Additional event context on this page matters because recent insider activity includes Regan Andrew filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
0.00
PEG
0.00
P/B
0.00
P/S
0.01
EV/EBITDA
13.80
DCF Value
$-12,267.60
FCF Yield
-120.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
37.1%
Operating Margin
6.4%
Net Margin
2.4%
ROE
2.6%
ROA
0.5%
ROIC
0.9%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $696.4M | $51.0M | $1,300.00 |
| Q4 2025 | $0.00 | $-21.3M | $-231.44 |
| FY 2025 | $0.00 | $-39.2M | $-1,177.90 |
| Q3 2025 | $0.00 | $-7.1M | $-329.03 |
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
1.41
Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.